OP3 Cost-effectiveness of the U.S. FDA added sugar labeling policy for improving cardiometabolic health: microsimulation modelling study
C Kypridemos, Y Huang, J Liu, Y Lee, J Pearson-Stuttard, B Collins, P Bandosz, S Capewell, M O’Flaherty, R Micha, L Whitsel, P Wilde, D Mozaffarian
J Epidemiol Community Health Sep 2018, 72 (Suppl 1) A2; DOI: 10.1136/jech-2018-SSMabstracts.3